Title : Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus - Wang_2023_J.Infect.Public.Health_16_1709 |
Author(s) : Wang CY , Liao KM , Wang YH , Chen KH , Chuang S , Liu CJ , Shu CC , Wang HC |
Ref : J Infect Public Health , 16 :1709 , 2023 |
Abstract : Wang_2023_J.Infect.Public.Health_16_1709 |
ESTHER : Wang_2023_J.Infect.Public.Health_16_1709 |
PubMedSearch : Wang_2023_J.Infect.Public.Health_16_1709 |
PubMedID: 37729686 |
Wang CY, Liao KM, Wang YH, Chen KH, Chuang S, Liu CJ, Shu CC, Wang HC (2023)
Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus
J Infect Public Health
16 :1709
Wang CY, Liao KM, Wang YH, Chen KH, Chuang S, Liu CJ, Shu CC, Wang HC (2023)
J Infect Public Health
16 :1709